4 C
New York
Tuesday, March 9, 2021
- Advertisement -

TAG

Biotechnology Company

IGM Biosciences [NASDAQ: IGMS] Shares Clinical Data From IGM-2323 In Non-Hodgkin’s Lymphoma

IGM Biosciences, Inc. has reported the clinical data from the Phase I study of IGM-2323 at the 62nd American Society of Hematology (ASH)...

Latest news

- Advertisement -